CClinicalTrials.gg
Not yet recruitingNCT05851131Updated May 23, 2023

Surveying Knowledge, Attitudes, and Practices of Primary Care Physicians in Turkey Regarding Osteoporosis Management.

An observational study in Osteoporosis, sponsored by Uskudar State Hospital. Not yet recruiting. Open to participants aged 25 Years to 65 Years. Per ClinicalTrials.gov, last updated 2023-05-23.

Sponsored by Uskudar State Hospital · Observational

From the registry’s dates

  • Primary completion was expected by Dec 2023, 2 years 10 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Ecologic or community
Time perspective
Prospective
Enrollment
200
Ages
25 Years to 65 Years
Sex
All
01

Study summary

This study aims to assess the knowledge of primary care physicians on the diagnosis and treatment of osteoporosis.

Read the detailed description

Multiple choice questions will be used to assess information related to the diagnosis and treatment of osteoporosis, including knowledge of various medications, their mechanisms of action and side effects, and recommended dosage of vitamin D supplementation. The participating physicians will also be asked about their sources of knowledge acquisition and how they keep updated on this topic, as well as their self-evaluation of knowledge. Furthermore, background information will be collected, including professional and demographic characteristics. A questionnaire previously used in other studies will be adapted for the study based on the 'Updated approach for the management of osteoporosis in Turkey: a consensus report'.

02

Conditions studied

  • Osteoporosis

Browse trials for

03

In context

Osteoporosis

1,640 studies on the registry are indexed under Osteoporosis; 212 are open to participants now.

This study's planned enrollment of 200 is above the median of 174 across 446 observational studies indexed under Osteoporosis.

Browse Osteoporosis studies →

Lead sponsor

Uskudar State Hospital is the lead sponsor of 27 studies on the registry; 23 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
25 Years to 65 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Family physician assistants, family physician specialists and general practitioners working in Turkey.

Inclusion criteria

  • Giving consent.
  • Working as a family physician assistant, family physician specialist or general practitioner in Turkey.

Exclusion criteria

Exclusion Criteria:

  • Not giving consent.
  • Having any physical or mental illness that may prevent reading, understanding and filling out the form.
05

Study design

Observational model
Ecologic or community
Time perspective
Prospective
Enrollment
200 participants (estimated)
Patient registry
No

Groups and cohorts

  • Family physicians

    Family physicians working in Turkey who gave consent to participate in the study.

    Other: Approach to Diagnosis and Treatment of Osteoporosis Questionnaire

Interventions

  • OtherApproach to Diagnosis and Treatment of Osteoporosis Questionnaire

    The survey will use multiple-choice questions to assess primary care physicians' knowledge on the diagnosis and treatment of osteoporosis. The questions will cover various aspects, including medication options, their mechanisms of action, side effects, and recommended vitamin D supplementation dosages. The physicians will also be asked about their sources of knowledge and how they keep themselves updated on the topic, as well as their self-evaluation of their knowledge. Background information, such as their professional and demographic characteristics, will also be collected. The survey questionnaire used in other studies will be adapted for this survey based on the "Updated approach for the management of osteoporosis in Turkey: a consensus report."

06

What researchers measure

Primary outcomes

  1. Knowledge levels, attitudes and practices of primary care physicians in Turkey

    The survey will use multiple-choice questions to assess primary care physicians' knowledge on the diagnosis and treatment of osteoporosis. The questions will cover various aspects, including medication options, their mechanisms of action, side effects, and recommended vitamin D supplementation dosages. The physicians will also be asked about their sources of knowledge and how they keep themselves updated on the topic, as well as their self-evaluation of their knowledge. Background information, such as their professional and demographic characteristics, will also be collected. The survey questionnaire used in other studies will be adapted for this survey based on the "Updated approach for the management of osteoporosis in Turkey: a consensus report."

    Time frame: 1 day

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided — Individual participant data will be shared upon reasonable request by the corresponding author.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 23, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05851131
Lead sponsor
Uskudar State Hospital
Responsible party
Mustafa Hüseyin Temel (Principal Investigator, Uskudar State Hospital) — Principal investigator
First posted
May 9, 2023
Start date
Aug 1, 2023 (estimated)
Primary completion
Dec 1, 2023 (estimated)
Completion
Apr 1, 2024 (estimated)
Last update
May 23, 2023

Study contacts

Mustafa H Temel, M.D.
Contact
mhuseyintemel@gmail.com
+905342714872
Fatih Bağcıer, M.D.
Contact
bagcier_42@hotmail.com
05442429042
Mustafa H Temel, M.D.
principal investigator · Uskudar State Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion